Suppr超能文献

小肠动力障碍、假性肠梗阻及其与组织病理学的功能关联:经验教训

Small Bowel Dysmotility, Pseudoobstruction, and Functional Correlation with Histopathology: Lessons Learned.

作者信息

Gonzalez Zorisadday, McCallum Richard

机构信息

Department of Gastroenterology, GI Motility Training and Research, Texas Tech University Health Sciences Center El Paso, 4800 Alberta, MSC 41007, El Paso, TX, 79905, USA.

Division of Gastroenterology, Center for Neurogastroenterology and GI Motility, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, 4800 Alberta, MSC 41007, El Paso, TX, 79905, USA.

出版信息

Curr Gastroenterol Rep. 2020 Feb 20;22(3):14. doi: 10.1007/s11894-020-0748-8.

Abstract

PURPOSE OF REVIEW

Small bowel dysmotility is a broad heterogeneous term that encompasses a wide range of gastrointestinal disorders resulting from abnormal gut motility. Chronic intestinal pseudo-obstruction (CIPO) is a severe, rare, and complex small bowel motility disorder at the extreme end of this spectrum. It is characterized by failure of the intestinal tract to propel contents, which results in signs and symptoms of bowel obstruction albeit in the absence of any obstructive lesion(s). In this article, we discuss up-to-date diagnostic techniques, management options, and histopathological findings in CIPO.

RECENT FINDINGS

We will emphasize the latest diagnostic methodologies and therapeutic options as well as enteric histopathologic abnormalities in patients with CIPO. CIPO continues to be a clinical challenge. Several novel pharmacological agents hold promise including gastrointestinal hormone agonists and prokinetics. Furthermore, histopathologic findings may help guide therapy and provide further prognostic significance. At present, nutritional support, symptom management, and avoidance of long-term complications are the mainstay of treatment in CIPO.

摘要

综述目的

小肠动力障碍是一个广泛的异质性术语,涵盖了由肠道动力异常导致的多种胃肠道疾病。慢性假性肠梗阻(CIPO)是这一疾病谱极端情况下的一种严重、罕见且复杂的小肠动力障碍。其特征为肠道无法推动内容物,从而导致肠梗阻的体征和症状,尽管不存在任何梗阻性病变。在本文中,我们讨论CIPO的最新诊断技术、治疗选择和组织病理学发现。

最新发现

我们将重点介绍CIPO患者的最新诊断方法、治疗选择以及肠道组织病理学异常。CIPO仍然是一项临床挑战。几种新型药物有望发挥作用,包括胃肠激素激动剂和促动力药。此外,组织病理学发现可能有助于指导治疗并提供进一步的预后意义。目前,营养支持、症状管理以及避免长期并发症是CIPO治疗的主要手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验